Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannabidiol + cannabis extract (Cantourage)
- Development stage
- Unknown
- Lead developer
- Cantourage Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual, Topical
01
Overview
Cantourage provides pharmaceutical-grade cannabidiol (CBD) and cannabis extracts as formulation starting materials for pharmacies. These botanical extracts are produced under EU GMP standards and are intended for the preparation of individualized medicinal cannabis products. As a distributor and processor, Cantourage sources high-quality cannabis materials globally to facilitate patient access to cannabinoid-based therapies in the European market. The extracts contain a profile of cannabinoids that interact with the endocannabinoid system, with CBD acting as a negative allosteric modulator of CB1 and CB2 receptors, an antagonist at GPR55, and an agonist at TRPV1 receptors, contributing to its diverse therapeutic potential in conditions such as chronic pain, epilepsy, and inflammatory disorders.
- Other names
- CBDcannabidiolcannabis extracts
02
Targets
CNR1 (Cannabinoid receptor 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)GPR55 (G protein-coupled receptor 55)
Beyond the preview
Go deeper on cannabidiol + cannabis extract (Cantourage).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannabidiol + cannabis extract (Cantourage).